WHOOP is all in on women’s health.
What’s happening: The wearable company introduced female-specific biomarker testing alongside enhanced context-aware features.
In-depth. Combining 11 undertested hormonal biomarkers, biometric data, and AI, WHOOP is personalizing life stage guidance for women. Adding to cycle tracking, users will have access to Hormonal Symptom Insights and Predictions on cycle length, symptoms, and irregularities.
New era. Broadening its ecosystem, WHOOP has invested in longevity with Advanced Labs, biological age estimations, and strength tracking while also exploring glucose monitoring
With its female user base growing 150% YoY, WHOOP is doubling down — adding 600+ employees and accelerating global expansion to advance its Personal Health OS.
Targeted tracking. Across wearables, diagnostics, and telehealth, women’s health is becoming a key proving ground.
From Oura’s custom LLM and Clair’s hormone tracker to targeted bloodwork from Midi, Tia, and Parsley, brands are moving from reactive symptom logging to more proactive, personalized guidance.
Punchline: More than one-off features, WHOOP’s tailoring its platform to offer clear, trusted guidance for women.
